相关实验视频
Updated: May 26, 2025

06:08
Formulating and Characterizing an Exosome-based Dopamine Carrier System
Published on: April 4, 2022
3.0K
从iPSC衍生出来的外体作为安福特素B载体:一种有前途的方法来对抗加密球菌脑膜炎
Jingyu Zhao1,2, Wei Fang3, Yangjie Gao1
1Department of Dermatology, Third Affiliated Hospital of Naval Medical University, Shanghai, China.
Frontiers in microbiology
|February 25, 2025
概括
诱导的多能干细胞衍生异体体载有安福特素B,在治疗加密球菌脑膜炎时显示出增强的疗效和降低的毒性. 这种新型的外体-AmB复合体为中枢神经系统真菌感染提供了一个有前途的新策略.
科学领域:
- 生物医学工程 生物医学工程
- 纳米医学是一种纳米医学.
- 传染性疾病 传染性疾病
背景情况:
- 加密球菌脑膜炎 (CM) 是一种危及生命的感染,特别是在艾滋病毒患者中.
- 氨酸B (AmB) 是主要的治疗方法,但在血脑屏障的透和毒性方面面临挑战.
研究的目的:
- 调查诱导多能干细胞衍生的外体细胞 (iPSC-Exos) 作为AmB.的载体的潜力.
- 通过降低AMB毒性来提高CM治疗的有效性和安全性.
主要方法:
- iPSC-Exos被隔离并进行了表征.
- 在iPSC-Exos中装载了AMB.
- 细胞毒性,细胞亡和溶血效应在体外进行了评估.
- 在密码球菌感染的小鼠模型中评估了疗效和毒性.
主要成果:
- 该iPSC-Exo/AmB复合体在体外细胞毒性和体内/肝毒性有所降低.
- 与传统的AmB.相比,该综合体对Cryptococcus的最小抑制度 (MIC) 显著较低.
- 观察到小鼠大脑中的真菌负荷减少和较低的血清炎症因子.
结论:
- iPSC-Exo/AmB代表了CM.的有前途的治疗策略.
- 这种方法可以提高AMB的疗效,同时减轻其毒性.
- 它具有治疗中枢神经系统耐火性真菌感染的潜力.
相关概念视频
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K

